Technologies
PDF


WARF: P150131US02

Noninvasive Assay for Bovine Embryo Quality


INVENTORS -

Hasan Khatib, Jenna Kropp

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in improving in vitro fertility success in dairy cattle using microRNAs as biomarkers for embryo quality.
OVERVIEWSelection intensity for higher milk production in dairy cattle has contributed to a decline in fertility, posing a challenge to dairy producers. Despite technological advances, the pregnancy rate of cows following in vitro fertilization (IVF) is only 45 percent, with increased risk for abortion and stillbirth.

Conventionally, assessment of the quality and potential of embryos produced in vitro is largely based on morphology. However, morphologically similar embryos differ in developmental capacity likely due to underlying genetics. Moreover, the process is subjective and requires invasive sampling of the embryo and parental tissue.

There is clear and commercial opportunity for a noninvasive method that supports the efficient selection of high quality embryos. Such a method would improve the odds of successful IVF procedures, saving tens of thousands of dollars and reducing failed pregnancies.
THE INVENTIONUW–Madison researchers have identified 11 microRNAs (miRNAs) and 18 mRNAs as indicators of healthy IVF embryo development. They discovered that the miRNAs are differentially expressed between bovine blastocyst-stage embryos and those that fail to develop (‘degenerates’). This is the first report that miRNA levels in the culture medium differ among embryos of different developmental fate and can be used as indicators of embryo viability.
APPLICATIONS
  • Embryo transfer services for cattle
  • Potential use for other mammals including human IVF
KEY BENEFITS
  • New method is noninvasive and nonsubjective.
  • Potentially significant cost savings
STAGE OF DEVELOPMENTThe researchers used small-RNA sequencing technology to identify both known and novel miRNAs in IVF culture media of embryos of varying competence, and found that they could be used as molecular markers of embryo quality.

Specifically, sequencing revealed 11 differentially expressed miRNAs in culture media conditioned by either blastocysts or degenerate embryos. By comparing the miRNAs from healthy embryos and those from degenerate embryos in three different IVF experiments, the researchers found that high expression levels of the 11 specific miRNAs in media correlated with degenerate embryo development.
Contact Information
For current licensing status, please contact Emily Bauer at emily@warf.org or 608-960-9842.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.